Glasgow Early Treatment Arm FavIpiravir (GETAFIX): A randomized controlled study of favipiravir as an early treatment arm in COVID-19 hospitalized patients (COVID-19)

Project: Research

Project Details

StatusActive
Effective start/end date18/05/20 → 17/11/20

Funding

  • Chief Scientist's Office CSO: £22,600.00
View all
View less